Log In
Print
BCIQ
Print
Print this Print this
 

Ibrance, palbociclib (PD-0332991)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionOral small molecule cyclin dependent kinase 4 (CDK4) and CDK6 inhibitor
Molecular Target Cyclin dependent kinase 4 (CDK4) ; Cyclin dependent kinase 6 (CDK6)
Mechanism of ActionCyclin dependent kinase (CDK) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today